Top 10 Quality Assurance Service Companies of 2021
December 14, 2021
TRI has been honored to be included in the Top 10 Quality Assurance Service Companies of 2021 by Pharma Tech Outlook. A panel of industry experts along with the editorial panel of Pharma Tech Outlook indexed the winning organizations.
TRI to Support BARDA’s Clinical Studies Network
December 16, 2020
Technical Resources International, Inc. (TRI) has been awarded the Clinical Studies Network (CSN) Clinical Trial Planning and Execution (CTPE) Contract in support of the Biomedical Advanced Research and Development Authority (BARDA), which is part of the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR).
TRI to Support the ACTIV-1 IM Study for Treating COVID-19
October 19, 2020
Technical Resources International, Inc. (TRI) has been awarded a contract to conduct the Randomized Master Protocol for Immune Modulators for Treating COVID-19 (ACTIV-1 IM) study under the Biomedical Advanced Research and Development Authority’s (BARDA) Medical Countermeasures Clinical Studies Network, in collaboration with the National Institutes of Health (NIH). Some COVID-19 patients experience an immune response in which the immune system unleashes excessive amounts of proteins that trigger inflammation — called a “cytokine storm” — that can lead to acute respiratory distress syndrome, multiple organ failure and other life-threatening complications. ACTIV-1 IM will evaluate the safety and efficacy of three immune modulator drugs designed to restore balance to an overactive immune system.
Pharma Tech Outlook Names TRI Top Analytics Solution Provider
July 1, 2018
TRI is pleased to announce that Pharma Tech Outlook, named TRI among the Top 10 Analytics Solution Providers for 2018. The award, given to distinctively prominent analytics providers in the Pharmaceutical and Life Sciences industry, recognizes TRI’s cutting-edge Data Analytics Team. The application of analytics tools to clinical research data can produce powerful predictive and descriptive insights and is utilized by companies to streamline outcomes. TRI specializes in applying data science to health research decision-making by creating a visual data showcase, allowing clients to discover trends, visualize patterns, identify abnormalities, and create innovative solutions.
Pharma Tech Outlook Names TRI Top eClinical Trial Management Solution Provider
July 1, 2018
TRI is pleased to announce that Pharma Tech Outlook has recognized TRI as a Top 10 eClinical Trial Management Solutions Provider for 2018. With several Clinical Trial Management Systems available, the award distinguishes solution providers offering extensive knowledge and innovative processes to maneuver the dynamic eClinical landscape. TRI’s acute understanding of the dynamic challenges and requirements in the drug, biologic, and medical device development industry allows TRI to successfully guide clients through an increasingly electronic clinical trial management space.
TRI Awarded Best Woman-Owned Business Enterprise CRO+ by GHP Magazine
September 1, 2016
We are pleased to announce TRI has been honored with a 2016 International Life Sciences Award for Best Woman-Owned Business Enterprise (WBE) CRO+ by Global Health and Pharma (GHP). This merit-based award recognizes the innovation, dedication, and commitment shown by life sciences professionals and firms across the globe.
TRI is Honored with 2014 National Library of Medicine Honor Awards
December 3, 2014
TRI is pleased to announce TRI staff members have been honored with two National Library of Medicine (NLM) Honor Awards under the U.S. Department of Health and Human Services during the 2014 NLM Honor Awards Ceremony taking place at the Lister Hill Auditorium.
TRI is Honored with 2014 NIH Merit Award
December 2, 2014
TRI is pleased to announce TRI staff members have been honored with a 2014 National Institutes of Health (NIH) Merit Award under the U.S. Department of Health and Human Services. The NIH Merit Award is in recognition for notable contributions to the National Cancer Institute (NCI) Cancer Therapy Evaluation Program (CTEP).
TRI’s Director of Quality Assurance, Dr. Susan Leister, to Speak at SOCRA Annual Conference
September 5, 2014
TRI’s Director of Quality Assurance, Dr. Susan Leister, is presenting at the upcoming Society of Clinical Research Associates (SOCRA) 23rd Annual Conference on September 19-21, 2014 in Orlando, FL. The SOCRA Annual Conference is focused on harnessing the tides of innovation to advance clinical research practice.
Dr. Leister’s presentation, “FDA Inspection Preparedness” covers a basic understanding of FDA inspections, the general purpose of the inspection, preparation strategies, and outcomes to assist clinical sites in developing an inspection readiness culture of compliance. Also discussed will be possible outcomes of an FDA inspection and how to respond to the FDA.
TRI is Honored Among the Inc. 500 | 5,000
September 3, 2014
Technical Resources International, Inc. (TRI) is honored among the Inc. 500 | 5,000 fastest growing privately owned companies in the U.S. TRI is a five time Inc. Honoree.
TRI’s Director of Quality Assurance, Dr. Susan Leister, to Speak at ACRP 2014
January 13, 2014
TRI’s Director of Quality Assurance, Dr. Susan Leister, is presenting at the upcoming Association of Clinical Research Professionals (ACRP) Global Conference & Exhibition on April 26-29, 2014 in San Antonio, Texas. The ACRP’s Global Conference & Exhibition is focused on professional growth, and individual development through education, exchange, and networking within the clinical research industry.
Dr. Leister’s presentation, “An Effective Corrective and Preventive Action Program (CAPA)” covers the CAPA process, how to implement an effective system using a risk-based approach, and review the key elements of a CAPA report. In addition, the basic principles of root cause analysis are reviewed.
TRI Contributes to a National Cancer Institute Study for Cancer Treatment
December 6, 2013 - Press Release
TRI’s Data Management and Biostatistics staff contributed to a study on the response to cancer therapy of an intact population of microorganisms living in the intestine. The study was a collaborative effort with scientists at the National Cancer Institute. Led by Romina Goldszmid, Ph.D. and Giorgio Trinchieri, M.D., both at NCI, it was published Nov. 22, 2013, in Science.
TRI’s Video Production for Montgomery County, Maryland Goes Viral
December 2, 2013 - Press Release
TRI’s instructional video production for Montgomery County’s Division of Solid Waste Services titled “Composting-Make it Happen: A Guide to Backyard Composting” explains the composting process, the elements of quality compost, the creation and maintenance of bins, and the solutions to common composting challenges.
TRI is Honored Among the Inc. 500 | 5,000
August 13, 2013 - Press Release
Technical Resources International, Inc. (TRI) is honored among the Inc. 500 | 5,000 fastest growing privately owned companies in the U.S.
TRI Supports USTDA China Public Health Emergency Response and Management Study Tour
July 5, 2013 - Press Release
Technical Resources International Inc. (TRI) supports the United States Trade and Development Agency (USTDA) in its sponsorship of a Study Tour for a delegation of key government leaders from China's emergency management and response sectors to visit and learn about U.S. companies specializing in emergency management and response.